Leukocyte depletion during CPB: effects on inflammation and lung function

Célio Gomes de Amorim1, Luiz Marcelo Sá Malbouisson, Francisco Costa da Silva

  • 1Discipline of Anesthesiology-Instituto do Coração, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil, celioamorim@uol.com.br.

Inflammation
|October 5, 2013
PubMed

Insights

Leukocyte filtration during cardiopulmonary bypass (CPB) temporarily reduced neutrophil counts and improved lung function in coronary artery bypass grafting (CABG) patients. However, long-term benefits were not observed, with only transient reductions in IL-10 levels.

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Pulmonary Medicine

Background:

  • Cardiopulmonary bypass (CPB) is associated with systemic inflammation and pulmonary dysfunction.
  • Coronary artery bypass grafting (CABG) frequently utilizes CPB, necessitating strategies to mitigate adverse effects.

Purpose of the Study:

  • To investigate the impact of leukocyte filtration during CPB on inflammatory markers and lung function post-CABG.
  • To compare outcomes between patients undergoing standard CPB versus CPB with leukocyte filtration.

Main Methods:

  • A prospective randomized study comparing CPB leukocyte filtration (n=9) against standard CPB (n=11) in CABG patients.
  • Evaluation of computed tomography, oxygenation (PaO2/FiO2), leukocyte counts, hemodynamic data, shunt fraction, interleukins (IL-10), elastase, and myeloperoxidase.
  • Statistical analysis using two-factor ANOVA for repeated measurements.

Main Results:

  • The leukocyte filtration group exhibited reduced neutrophil counts within 50 minutes of CPB.
  • A lower shunt fraction was observed up to 6 hours post-surgery in the filtered group.
  • Serum levels of IL-10 were significantly lower at the end of surgery in patients who received leukocyte filtration.

Conclusions:

  • Leukocyte depletion during CPB transiently reduces neutrophil sequestration and IL-10 levels.
  • CPB leukocyte filtration offers only temporary improvements in lung function post-CABG.
  • Further research may be needed to optimize filtration strategies for sustained benefits.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...